Easton Pharmaceutica Stock Performance
| EAPH Stock | USD 0.00001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Easton Pharmaceutica are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Easton Pharmaceutica are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Easton Pharmaceutica demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:3000 | Last Split Date 2009-04-30 |
| Begin Period Cash Flow | 280.2 K | |
| Total Cashflows From Investing Activities | -18.8 K | |
| Free Cash Flow | -188.5 K |
Easton Pharmaceutica Relative Risk vs. Return Landscape
If you would invest 0.00 in Easton Pharmaceutica on November 27, 2025 and sell it today you would earn a total of 0.00 from holding Easton Pharmaceutica or generate 9.223372036854776E16% return on investment over 90 days. Easton Pharmaceutica is currently generating 16.6667% in daily expected returns and assumes 129.0994% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Easton, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Easton Pharmaceutica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Easton Pharmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Easton Pharmaceutica can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Easton Pharmaceutica is way too risky over 90 days horizon | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica appears to be risky and price may revert if volatility continues | |
| Easton Pharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures |
Easton Pharmaceutica Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Easton Stock often depends not only on the future outlook of the current and potential Easton Pharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Easton Pharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.3 B | |
| Shares Float | 1.3 B |
Easton Pharmaceutica Fundamentals Growth
Easton Stock prices reflect investors' perceptions of the future prospects and financial health of Easton Pharmaceutica, and Easton Pharmaceutica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Easton Stock performance.
| Return On Equity | -0.0269 | ||||
| Return On Asset | -0.0083 | ||||
| Current Valuation | 2.14 M | ||||
| Shares Outstanding | 1.34 B | ||||
| Price To Earning | (22.00) X | ||||
| Price To Book | 0 X | ||||
| Price To Sales | 0.06 X | ||||
| Gross Profit | 201.4 K | ||||
| EBITDA | (188.54 K) | ||||
| Net Income | (188.54 K) | ||||
| Cash And Equivalents | 5.81 K | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 0.69 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (188.54 K) | ||||
| Market Capitalization | 13.45 K | ||||
| Total Asset | 10.19 M | ||||
| Retained Earnings | (39.82 M) | ||||
| Working Capital | (194.5 K) | ||||
| Current Asset | 297 K | ||||
| Current Liabilities | 137 K | ||||
About Easton Pharmaceutica Performance
By evaluating Easton Pharmaceutica's fundamental ratios, stakeholders can gain valuable insights into Easton Pharmaceutica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Easton Pharmaceutica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Easton Pharmaceutica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 47.67 | 45.29 | |
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.03) | (0.03) |
Things to note about Easton Pharmaceutica performance evaluation
Checking the ongoing alerts about Easton Pharmaceutica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Easton Pharmaceutica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Easton Pharmaceutica is way too risky over 90 days horizon | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica appears to be risky and price may revert if volatility continues | |
| Easton Pharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures |
- Analyzing Easton Pharmaceutica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Easton Pharmaceutica's stock is overvalued or undervalued compared to its peers.
- Examining Easton Pharmaceutica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Easton Pharmaceutica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Easton Pharmaceutica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Easton Pharmaceutica's stock. These opinions can provide insight into Easton Pharmaceutica's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |